Navigation Links
Herbicides, Fibrate Drugs May Block Taste Receptors
Date:10/27/2009

More research needed to determine the health consequences of compounds in question, experts say

TUESDAY, Oct. 27 (HealthDay News) -- Some common herbicides and cholesterol drugs block a nutrient-sensing receptor known as T1R3, researchers report.

"Compounds that either activate or block T1R3 receptors could have significant metabolic effects, potentially influencing diseases such as obesity, type II diabetes and metabolic syndrome," study author Dr. Bedrich Mosinger said in a news release. Mosinger is a geneticist at the Monell Chemical Senses Center in Philadelphia.

The receptor helps the body detect sweetness and the savory taste known as umami. It's found on the tongue and also appears to be in the intestine and pancreas.

According to scientists, the receptors notice that nutrients are in food and set off their processing.

In the study, recently published online in the Journal of Medicinal Chemistry, researchers looked at two compounds -- fibrates and phenoxy-herbicides -- to see if they had an effect on the receptors.

Fibrate drugs treat disorders such as high cholesterol and triglycerides. Phenoxy-herbicides, including the commonplace 2,4-D, are used to combat destructive weeds.

The researchers, from Monell and Mount Sinai School of Medicine in New York City, found that both classes of compounds blocked the receptor from activating.

"The metabolic consequences of short- and long-term exposures of humans to phenoxy-herbicides are unknown," Mosinger said. "This is because most safety tests were done using animals, which have T1R3 receptors that are insensitive to these compounds."

Ultimately, he said, "given the number of compounds used in agriculture, medicine and the food industry that may affect human T1R3 and related receptors, more work is needed to identify the health-related effects of exposure to these compounds."

More information
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. (Multimedia Version): Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management
2. Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management
3. Drugs for Inflammatory Bowel Might Increase Cancer Risk
4. Drugs for Irritable Bowel Might Increase Cancer Risk
5. Pitt researchers find candidates for new HIV drugs
6. Designing drugs and their antidotes together improves patient care
7. Risk of abnormally slow heart rate twice as high in those taking drugs to slow Alzheimers
8. Teen attitudes toward smoking linked to likelihood of drinking and using drugs
9. UCLA study identifies 2 chemicals that could lead to new drugs for genetic disorders
10. GENova Biotherapeutics secures new cancer drugs targets
11. Reportlinker Adds World Anti-Obesity Drugs Market Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 AngelWeddingDress, the premier women’s dress ... wedding dresses. View website of AngelWeddingDress.com to ... maternity wedding dresses online for a bridal party. AngelWeddingDress ... quality for them. Its maternity wedding dresses are specially ...
(Date:1/22/2015)... released a new blog post explaining the main features of ... Auto insurance quotes help many drivers find the best coverage ... an agent or visit an agency for price information. These ... http://autocarinsurancebest.com/ . , Every business who relies heavily on transportation ...
(Date:1/22/2015)... 2015 Yesterday, Senator Holly Mitchell ... Kristin Olsen (R-Modesto) were honored by the California ... biotechnology, biomedical science, medical device and pharmaceutical innovation ... the “2014 Life Sciences Champion” award from CHI ...
(Date:1/22/2015)... 22, 2015 EBSCO Information Services ... expanding their relationship in an effort to further promote visibility ... While EBSCO has long made AMA journals available via its ... for The JAMA Network. , Long known as ...
(Date:1/22/2015)... 22, 2015 Step into a macabre ... Science Museum of Virginia. Wicked Plants, the Museum’s latest ... unearths 75 poisonous, carnivorous and diabolical plants inside of ... to uncover the biochemical, physical and neurological processes between ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... folic acid fortification of enriched grains in the mid 1990s, ... and Canada with neural tube defects has declined by 20 ... institution of fortification, however, the rate at which new cases ... report researchers at the Jean Mayer USDA Human Nutrition Research ...
... of the journal Cancer Cell, published by Cell Press ... promyelocytic leukemia (APL) and identifies promising new avenues to ... ,Results from two new studies provide key mechanistic ... deadly type of leukemia.,APL is a cancer of the ...
... issue of the journal Cancer Cell, published by Cell ... potency and effectiveness of a tumor necrosis factor (TNF) ... , A new study identifies a combination ... promising treatment currently being used in clinical trials. ...
... to boost fruit and vegetable intake among young children could have ... Janet Cade and colleagues of Leeds University assessed the impact of ... 3,700 young students from 98 schools in the north of England. ... and nutrient intake. , It was seen that ...
... protect against the clustering of abnormal body chemistry known as ... of Epidemiology and Community Health. ,The syndrome has been ... and premature death. ,The findings are based on ... 59, all of whom were part of a long term ...
... Brandeis University study published in the July issue of ... require screening for substance abuse and mental health in ... , This may be a missed opportunity to ... only a fraction of whom currently receive treatment. ...
Cached Medicine News:Health News:Folicacid Fortification Very Beneficial 2Health News:Folicacid Fortification Very Beneficial 3Health News:Insights into Acute Promyelocytic Leukemia 2Health News:Insights into Acute Promyelocytic Leukemia 3Health News:New Cancer Therapy in Clinical Trial 2Health News:Britains Free Fruit -And -Vegetable -Scheme Falls Flat 2Health News:Screening for Behavioral Health 2
(Date:1/23/2015)... SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, ... where its Phase I trial of Lixte,s lead compound, LB‑100, ... institutions. John S. Kovach , M.D., the ... was planned to be completed at a single site. Accrual ...
(Date:1/23/2015)... , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... Directors has approved a share repurchase program. The open-ended ... million of Mallinckrodt plc ordinary shares. ... remain top priorities as we continue to pursue a ...
(Date:1/22/2015)... 22, 2015  ViewRay™, a privately held medical device company, ... distributor agreement with ITOCHU Corporation (Tokyo Stock Exchange TYO: ... the treatment of cancer in Japan ... world,s first and only MRI-guided radiation therapy system that ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... sodium injection) were also ... within 90 days-, BRIDGEWATER, N.J., Dec 10 ... total hospital,direct medical costs associated with VTE treatment are ... the use of low-molecular weight heparin,(LMWH) vs. unfractionated heparin ...
... 10 Alfacell Corporation,(Nasdaq: ACEL ) today reported ... The company recorded a net loss of approximately ... for the fiscal quarter ended Oct. 31,compared to a ... and diluted,common share, for the first quarter of fiscal ...
Cached Medicine Technology:Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 2Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 3Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 4Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 5Alfacell Reports Financial Results for First Quarter of Fiscal 2008 2Alfacell Reports Financial Results for First Quarter of Fiscal 2008 3Alfacell Reports Financial Results for First Quarter of Fiscal 2008 4Alfacell Reports Financial Results for First Quarter of Fiscal 2008 5
Blunt tipped forceps wlth a small grasping platform on each tip. For grasping fine membranes or grasping membranes adherent to the retinal surface....
Blunt tipped forceps with small, slightly rounded tips angled perpendicular to the shaft. For grasping peripheral membranes....
... Microdiathermy System features an advanced design, solid ... as well as many years of clinical ... optimum choice for the placement of discrete ... burns produce the maximum effect at the ...
Anterior chamber protein cell meter. Laser flare meter and cell-counting functions are included in this cell meter, with dramatically enhanced measurement of cell volume....
Medicine Products: